Indefinite Delivery Contract SPE2DB24D9640

Award Date 10/24/24
Last Date to Order 11/30/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Illinois. The $499,999,999 single-award IDC, valid through December 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The IDC covers an extensive portfolio of branded and generic...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 single-award IDC, with a period of performance through December 31, 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 single-award IDC, under the SPE2DB program, runs through December 31, 2025 and allows DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The IDC covers a vast array...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award IDC, valued at up to $499,999,999, runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $499,999,999 single-award IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued up to $499,999,999, covers the period from October 2, 2024 through December 31, 2025. Under this IDC, DMS Pharmaceutical Group will provide a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of military health facilities...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award IDC, valued at up to $499,999,999, runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The single-award IDC, valued up to $499,999,999, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. Key items included under this IDC span multiple therapeutic categories, such as naltrexone tablets, botulinum toxin...
This indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The single-award IDC, valued up to $499,999,999, covers the period from October 10, 2024 through December 31, 2025. Under this IDC, DMS Pharmaceutical Group will provide a comprehensive range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities...
This indefinite delivery contract (IDC) was awarded by the U.S. Defense Logistics Agency (DLA) to the woman-owned small business DMS Pharmaceutical Group Inc. The single-award IDC, valued up to $499,999,999, provides the DLA with a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this IDC vehicle, DMS Pharmaceutical Group supplies both routine and critical medications, including branded and generic...

This single-award Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide.

The IDC covers a comprehensive portfolio of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. Key product categories include flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications. This IDC complements DMS Pharmaceutical Group's existing prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites, solidifying the company's role as a crucial supplier in the federal pharmaceutical supply chain.

Generated 12/1/24, 9:04 AM